Johannes Hofland

36PUBLICATIONS
102CO-AUTHORS
Molecular targetsSolid tumoursRespiratory diseasesGene and molecular therapyCivil procedure
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Aug 06, 2026
Ersodetug for Refractory Hypoglycemia Due to Malignant Insulin-Secreting Tumors.

|Aug 01, 2026
Safety of glucagon-like peptide-1 receptor agonists in neuroendocrine neoplasms.

|Jul 27, 2026
Cardiogenic shock due to pheochromocytoma-induced catecholamine crisis in a young woman.

|Jun 30, 2026
Controversies in NEN: An ENETS position statement on the interchangeability of somatostatin receptor PET tracers.

|Apr 20, 2026
Unravelling mesenteric fibrosis in small intestinal neuroendocrine tumours and implications for clinical management.

|Apr 14, 2026
The effect of LysaKare infusion on serum potassium levels in patients with gastroenteropancreatic neuroendocrine tumours eligible for treatment with [177Lu]Lu-DOTA-TATE: A post-authorisation safety study.

Johannes Hofland, Chiara Maria Grana, Martin O Weickert

Pageof 6

Frequent Collaborators

17 joint publications

Wouter W de Herder

6 joint publications

Merijn C F Mulders

5 joint publications

Simona Grozinsky-Glasberg

5 joint publications

Richard A Feelders